Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OXGP:GR

1.389 EUR 0.034 2.39%

As of 15:11:11 ET on 04/17/2015.

Snapshot for OXiGENE Inc (OXGP)

Open: 1.418 Day's Range: 1.389 - 1.462 Volume: 1,220
Previous Close: 1.423 52wk Range: 1.173 - 2.433 1-Yr Rtn: -34.26%

Stock Chart for OXGP

No chart data available.
  • OXGP:GR 1.462
  • 1D
  • 1M
  • 1Y
1.423
Interactive OXGP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OXGP

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.6300
Est. PEG Ratio -
Market Cap (M EUR) 36.87
Shares Outstanding (M) 26.54
30 Day Average Volume 3,300
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OXGP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OXGP

OXiGENE Inc. is a pharmaceutical company that develops therapeutics to treat cancer and eye diseases. The Company focuses on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.

David J Chaplin "Dai"President/CEOBarbara RichingVP/CFO
More Company Profile & Key Executives for OXGP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil